Clinical reference
Antidiabetic / Weight management · Glucagon-like peptide-1 (GLP-1) receptor agonist · Endocrinology, Pediatrics
Liraglutide is a GLP-1 receptor agonist used for type 2 diabetes (Victoza) and chronic weight management (Saxenda). Same subcutaneous pen-injector 18 mg/3 mL (3 mL); contains phenol, propylene glycol. Inject SC in abdomen, thigh, or upper arm any time of day without regard to meals. Prime each new prefilled pen before first use; use a new needle for each…